Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
about
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@en
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@nl
type
label
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@en
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@nl
prefLabel
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@en
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@nl
P2093
P2860
P356
P1433
P1476
Targeted sequencing reveals TP ...... lance of head and neck cancer.
@en
P2093
Joost H van Ginkel
Remco de Bree
Robert J J van Es
Stefan M Willems
Wendy W J de Leng
P2860
P304
61575-61586
P356
10.18632/ONCOTARGET.11196
P407
P577
2016-08-11T00:00:00Z